kabutan

J-Pharma Co.,Ltd.(520A) Financial Results

520A
TSE Growth
J-Pharma Co.,Ltd.
555
JPY
+1
(+0.18%)
May 1, 3:30 pm JST
3.52
USD
May 1, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2022 -1,076 -1,080 -194.9 0 J-GAAP
Mar, 2023 -1,086 -1,098 -190.6 0 J-GAAP
Mar, 2024 -1,722 -1,640 -1,652 -263.6 0 J-GAAP
Mar, 2025 -1,595 -1,527 -1,499 -184.1 0 J-GAAP
Mar, 2026 Guidance -3,861 -2,891 -2,724 -152.8 0 Mar 25, 2026 J-GAAP
YoY -142.1% -89.3% -81.7% +17.0%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record -1,595 -930 -931 -184.1
Fiscal Year Mar, 2025 Mar, 2021 Mar, 2021 Mar, 2025
Second Half
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Mar, 2024 -1,722 -1,440 -1,411 -29 925 1,073 88.90 J-GAAP
Mar, 2025 -1,595 -1,694 -1,694 0 2,924 2,301 80.57 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2025 -2,533 -2,047 -1,876 -157.6 Mar 25, 2026 J-GAAP
YoY
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2025 -571 -452 -448 -37.6 Mar 25, 2026 J-GAAP
YoY
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record -571 -452 -448 -37.6
Fiscal Year Dec, 2025 Dec, 2025 Dec, 2025 Dec, 2025
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Mar, 2023 -3,948.01 80.4 1,751 1,407 J-GAAP
Mar, 2024 -4,633.35 78.7 1,207 950 J-GAAP
Mar, 2025 -3,673.10 45.7 2,856 1,305 J-GAAP
Apr - Dec, 2025 66.2 2,952 1,955 -1,876 Mar 25, 2026 J-GAAP